Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 234
Filter
1.
Am J Transplant ; 16(2): 468-83, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26663569

ABSTRACT

Genotyping graft livers by short tandem repeats after human living-donor liver transplantation (n = 20) revealed the presence of recipient or chimeric genotype cases in hepatocytes (6 of 17, 35.3%), sinusoidal cells (18 of 18, 100%), cholangiocytes (15 of 17, 88.2%) and cells in the periportal areas (7 of 8, 87.5%), suggesting extrahepatic cell involvement in liver regeneration. Regarding extrahepatic origin, bone marrow mesenchymal stem cells (BM-MSCs) have been suggested to contribute to liver regeneration but compose a heterogeneous population. We focused on a more specific subpopulation (1-2% of BM-MSCs), called multilineage-differentiating stress-enduring (Muse) cells, for their ability to differentiate into liver-lineage cells and repair tissue. We generated a physical partial hepatectomy model in immunodeficient mice and injected green fluorescent protein (GFP)-labeled human BM-MSC Muse cells intravenously (n = 20). Immunohistochemistry, fluorescence in situ hybridization and species-specific polymerase chain reaction revealed that they integrated into regenerating areas and expressed liver progenitor markers during the early phase and then differentiated spontaneously into major liver components, including hepatocytes (≈74.3% of GFP-positive integrated Muse cells), cholangiocytes (≈17.7%), sinusoidal endothelial cells (≈2.0%), and Kupffer cells (≈6.0%). In contrast, the remaining cells in the BM-MSCs were not detected in the liver for up to 4 weeks. These results suggest that Muse cells are the predominant population of BM-MSCs that are capable of replacing major liver components during liver regeneration.


Subject(s)
Bone Marrow Transplantation , Liver Diseases/surgery , Liver Regeneration/physiology , Mesenchymal Stem Cell Transplantation , Postoperative Complications/therapy , Adult , Animals , Child , Female , Humans , Immunoenzyme Techniques , In Situ Hybridization, Fluorescence , Liver Transplantation/adverse effects , Male , Mice , Mice, Inbred ICR , Mice, SCID , Prognosis
2.
Gene Ther ; 19(2): 219-27, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21697955

ABSTRACT

A promoter library was developed that is composed of DNA fragments constructed by randomly elongating the cis-acting elements of transcription factors presumably activated in prostate cancer by radiation, and linking to the TATA-box sequence. One promoter with the strongest reactivity to X-ray in the LNCap cells of the library was chosen and improved by the introduction of random mutations. The resultant promoter was designated clone 880-8, showing the highest dose-dependent activity enhancement with X-ray irradiation (X-irradiation). A recombinant retrovirus expressing the luciferase gene under the control of clone 880-8 was infected into LNCap cells that showed 9.12Ā±0.36-fold enhancement of luciferase activity 12 h after X-irradiation at 10 Gy. When the infected cells were inoculated onto nude mice, enhancement of luciferase expression was 4.27Ā±1.36-fold 12 h after X-irradiation at 10 Gy. When LNCap was infected with another recombinant carrying the fcy::fur gene downstream from clone 880-8, fcy::fur expression was enhanced by X-irradiation. It was also shown to increase the dose-dependent cell killing ratio with 5-FC as compared with a counterpart without X-irradiation. These results suggest that the method used in this study is effective to construct a promoter responsive to stimulation. Such promoters can be used for stimulation-controlled gene therapies.


Subject(s)
Genetic Therapy/methods , Luciferases/metabolism , Promoter Regions, Genetic , Prostatic Neoplasms/metabolism , TATA Box/genetics , Animals , Cell Line, Tumor , Dose-Response Relationship, Radiation , Gene Expression Regulation, Neoplastic/radiation effects , Humans , Luciferases/genetics , Male , Mice , Prostatic Neoplasms/genetics , Transcription Factors/genetics , Transplantation, Heterologous , X-Rays
3.
Eur J Neurol ; 19(6): 905-10, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22288427

ABSTRACT

BACKGROUND AND PURPOSE: Shortened telomere length has been considered to be associated with various age-related diseases, especially in dementia such as Alzheimer's disease and vascular dementia. However, changes in telomere length in dementia with Lewy bodies (DLB) remain unclear. To elucidate these changes, we set out to determine telomere length in peripheral leukocytes as well as the level of urinary 8-hydroxy-deoxyguanosine (8-OHdG) as a marker of oxidative stress in DLB. METHODS: Blood samples were obtained from 33 patients with a clinical diagnosis of probable DLB and 35 age-matched, non-demented elderly controls (NEC). Telomere length was assessed by quantitative real-time polymerase chain reaction of genomic DNA extracted from leukocytes, whereas oxidative stress was assessed on the basis of urine 8-OHdG level, which was measured using high-performance liquid chromatography. RESULTS: Telomere length was significantly shorter in the DLB group than in the NEC group. Urinary 8-OHdG levels were significantly higher in the DLB group than in the NEC group. There was a negative correlation between telomere length and age in the DLB group; however, there were no significant relationships between telomere length and clinical findings including disease duration, severity of cognitive decline, presence or absence of fluctuation in cognitive function, visual hallucinations, and Parkinsonism. In both groups, the correlation between telomere length and urinary 8-OHdG levels was not significant. CONCLUSIONS: These findings indicate that the etiopathology of DLB is considered to be an accelerated aging process.


Subject(s)
Lewy Bodies/ultrastructure , Lewy Body Disease/pathology , Telomere/pathology , 8-Hydroxy-2'-Deoxyguanosine , Aged , Aged, 80 and over , Deoxyguanosine/analogs & derivatives , Deoxyguanosine/urine , Female , Humans , Lewy Bodies/pathology , Lewy Body Disease/urine , Male , Severity of Illness Index , Statistics as Topic
4.
J Exp Med ; 187(11): 1779-88, 1998 Jun 01.
Article in English | MEDLINE | ID: mdl-9607919

ABSTRACT

Platelet-activating factor (PAF) is a potent phospholipid mediator with diverse biological activities in addition to its well-known ability to stimulate platelet aggregation. Pharmacologic studies had suggested a role for PAF in pregnancy, neuronal cell migration, anaphylaxis, and endotoxic shock. Here we show that disruption of the PAF receptor gene in mice caused a marked reduction in systemic anaphylactic symptoms. Unexpectedly, however, the PAF receptor-deficient mice developed normally, were fertile, and remained sensitive to bacterial endotoxin. These mutant mice clearly show that PAF plays a dominant role in eliciting anaphylaxis, but that it is not essential for reproduction, brain development, or endotoxic shock.


Subject(s)
Anaphylaxis/immunology , Lipopolysaccharides/immunology , Platelet Membrane Glycoproteins/physiology , Receptors, Cell Surface , Receptors, G-Protein-Coupled , Animals , Gene Targeting , Heart/physiology , Homeostasis , Male , Mice , Platelet Membrane Glycoproteins/deficiency , Platelet Membrane Glycoproteins/genetics , Reproduction , Shock, Septic/immunology
5.
Gut ; 58(6): 820-4, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19052022

ABSTRACT

OBJECTIVE: There is a concept that pancreatitis results from an imbalance of proteases and their inhibitors within the pancreatic parenchyma. It has been recently shown that a loss-of-function variant, c.571G>A (p.G191R), in the anionic trypsinogen (PRSS2) gene protects against chronic pancreatitis in European populations. Here we examined the association of the p.G191R variant with pancreatic disorders in Japan. METHODS: Genomic DNA was prepared from 378 healthy controls and 604 patients with pancreatic disorders (241 patients with chronic pancreatitis, 174 with acute pancreatitis, and 189 with pancreatic neoplasm). Mutational analysis of the PRSS2 gene was performed by polymerase chain reaction-restriction fragment length polymorphism and direct sequencing. RESULTS: The heterozygous p.G191R variant was found in three of 241 (1.2%) patients with chronic pancreatitis, in seven of 174 (4.0%) patients with acute pancreatitis, and in 12 of 189 (6.3%) patients with pancreatic neoplasm. The p.G191R variant was found in 25 (two were homozygous and 23 were heterozygous) of 378 (6.6%) healthy controls. The p.G191R frequency in patients with chronic pancreatitis was lower than that in healthy controls (p = 0.001; odds ratio (OR) 0.178; 95% confidence interval (CI) = 0.057 to 0.561). The p.G191R frequency was lower in patients with alcoholic (0.9%; p = 0.015; OR, 0.132; 95% CI, 0.022 to 0.779) and idiopathic (1.0%; p = 0.025; OR, 0.144; 95% CI, 0.025 to 0.851) chronic pancreatitis than that in healthy controls. There were no statistical differences in the p.G191R frequency between healthy controls and patients with acute pancreatitis or with pancreatic neoplasm. Patients with alcoholic acute pancreatitis (n = 59) had no variant carrier, and the p.G191R frequency was lower than that in healthy controls (p = 0.035). CONCLUSION: The p.G191R variant protected against alcoholic and idiopathic chronic pancreatitis as well as alcoholic acute pancreatitis in Japan.


Subject(s)
Mutation , Pancreatitis/genetics , Trypsin/genetics , Trypsinogen/genetics , Adenocarcinoma/genetics , Adenocarcinoma/metabolism , Adult , Aged , Alcohol Drinking/adverse effects , Case-Control Studies , DNA Mutational Analysis , Female , Gene Frequency , Genotype , Heterozygote , Homozygote , Humans , Japan , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/metabolism , Pancreatitis/metabolism , Pancreatitis, Acute Necrotizing/genetics , Pancreatitis, Acute Necrotizing/metabolism , Pancreatitis, Chronic/etiology , Pancreatitis, Chronic/genetics , Pancreatitis, Chronic/metabolism , Trypsin/metabolism , Trypsinogen/metabolism
6.
Science ; 288(5468): 1013-9, 2000 May 12.
Article in English | MEDLINE | ID: mdl-10807566

ABSTRACT

We show that, in the mouse, the core mechanism for the master circadian clock consists of interacting positive and negative transcription and translation feedback loops. Analysis of Clock/Clock mutant mice, homozygous Period2(Brdm1) mutants, and Cryptochrome-deficient mice reveals substantially altered Bmal1 rhythms, consistent with a dominant role of PERIOD2 in the positive regulation of the Bmal1 loop. In vitro analysis of CRYPTOCHROME inhibition of CLOCK: BMAL1-mediated transcription shows that the inhibition is through direct protein:protein interactions, independent of the PERIOD and TIMELESS proteins. PERIOD2 is a positive regulator of the Bmal1 loop, and CRYPTOCHROMES are the negative regulators of the Period and Cryptochrome cycles.


Subject(s)
Biological Clocks/physiology , Circadian Rhythm/physiology , Drosophila Proteins , Eye Proteins , Flavoproteins/metabolism , Nuclear Proteins/metabolism , Photoreceptor Cells, Invertebrate , Suprachiasmatic Nucleus/metabolism , Transcription Factors/metabolism , ARNTL Transcription Factors , Animals , Basic Helix-Loop-Helix Transcription Factors , Biological Clocks/genetics , CLOCK Proteins , Cell Cycle Proteins , Cell Line , Cell Nucleus/metabolism , Circadian Rhythm/genetics , Cryptochromes , Dimerization , Feedback , Female , Flavoproteins/genetics , Gene Expression Regulation , In Situ Hybridization , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Models, Biological , Mutation , Nuclear Proteins/genetics , Period Circadian Proteins , Protein Biosynthesis , RNA/metabolism , Receptors, G-Protein-Coupled , Trans-Activators/genetics , Trans-Activators/metabolism , Transcription Factors/genetics , Transcription, Genetic
7.
Endoscopy ; 40(4): 280-3, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18389445

ABSTRACT

BACKGROUND AND STUDY AIM: Endoscopic mucosal resection using a cap (EMR-C) is an established method for curative resection of early neoplastic lesions; prelooping of the snare may however be difficult and lead to imprecise resection. We therefore compared two modifications of the conventional technique using outer snare placement with an accessory channel in a prospective, nonrandomized study. PATIENTS AND METHODS: Between October 2004 and March 2007, 54 patients (men 37, women 17; mean age 71 years) underwent EMR. One method involved an internally retained snare (IRS) cap, with a fixed prelooped snare inside the cap; the other method used an externally guided snare (EGS) cap with the snare guided over an oblique cap. The main outcome parameters were specimen size, en bloc resection, and complications. RESULTS: There was no difference between use of the IRS and EGS cap methods in relation to specimen size (27.6 vs. 27.1 mm), or rates of en bloc resection (88.9 % vs. 83.3 %); only one perforation occurred, and this was in the EGS group. CONCLUSION: Both techniques appeared to provide similar efficacy, the inner rim of the IRS cap stabilizes aspiration of the lesion compared with the EGS cap that does not have it.


Subject(s)
Gastric Mucosa/surgery , Gastroscopy/methods , Stomach Neoplasms/surgery , Aged , Equipment Design , Female , Humans , Male , Prospective Studies , Statistics, Nonparametric , Treatment Outcome
8.
J Clin Invest ; 104(8): 1071-6, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10525045

ABSTRACT

Adult respiratory distress syndrome (ARDS) is an acute lung injury of high mortality rate, and the molecular mechanisms underlying it are poorly understood. Acid aspiration-induced lung injury is one of the most common causes of ARDS, characterized by an increase in lung permeability, enhanced polymorphonuclear neutrophil (PMN) sequestration, and respiratory failure. Here, we investigated the role of platelet-activating factor (PAF) and the PAF receptor (PAFR) gene in a murine model of acid aspiration-induced lung injury. Overexpression of the PAFR gene in transgenic mice enhanced lung injury, pulmonary edema, and deterioration of gas exchange caused by HCl aspiration. Conversely, mice carrying a targeted disruption of the PAFR gene experienced significantly less acid-induced injury, edema, and respiratory failure. Nevertheless, the efficiency of PMN sequestration in response to acid aspiration was unaffected by differences in PAFR expression level. The current observations suggest that PAF is involved in the pathogenesis of acute lung injury caused by acid aspiration. Thus, inhibition of this pathway might provide a novel therapeutic approach to acute lung injury, for which no specific pharmaceutical agents are currently available.


Subject(s)
Platelet Activating Factor/physiology , Platelet Membrane Glycoproteins/physiology , Receptors, Cell Surface , Receptors, G-Protein-Coupled , Respiratory Distress Syndrome/etiology , Animals , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Phospholipases A/physiology , Platelet Activating Factor/genetics , Platelet Membrane Glycoproteins/genetics , Respiratory Distress Syndrome/therapy
9.
Endoscopy ; 39(6): 566-9, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17554656

ABSTRACT

The technique of endoscopic submucosal dissection (ESD) needs special skills and involves a long procedure. We therefore developed a new type of dissection knife, the irrigation cap-knife (the Kume cap-knife attachment, which uses a fixed snare), that facilitates ESD by just sliding over the muscle layer with a coagulating current. The ESD procedure using the irrigation cap-knife was performed in seven patients with intramucosal gastric cancer. The tumor was separated from the surrounding normal mucosa using the insulated-tip knife. Submucosal dissection was then performed by pushing our device along the muscle layer while applying a coagulating current, at the same time as a grasping forceps, deployed through the accessory channel, was used to push the lesion away from the muscle layer. The rate of en bloc resection was 100% (7/7). The irrigating cap-knife was extremely useful for ESD of large intramucosal cancers in the stomach.


Subject(s)
Dissection/instrumentation , Gastric Mucosa/surgery , Gastroscopy/methods , Stomach Neoplasms/surgery , Aged , Female , Gastric Lavage , Humans , Male , Middle Aged , Neoplasm Staging , Stomach Neoplasms/pathology , Surgical Instruments
12.
J Bone Miner Res ; 16(5): 857-67, 2001 May.
Article in English | MEDLINE | ID: mdl-11341330

ABSTRACT

To apply osteoblasts to bone reconstruction, we proved that transplanted osteoblasts possessed the differentiated osteoblastic function and formed bonelike tissue in vivo after transplantation. First, we confirmed that dexamethasone (Dex) promoted the expression of osteoblastic phenotype in human osteoblast culture using reverse-transcription-polymerase chain reaction (RT-PCR). These osteoblasts were cultured for 10 days within collagen sponge, which consists of denatured type I collagen, in the presence or absence of 10(-7) M Dex. The osteoblasts along with collagen sponge were transplanted into the trapezius muscles of 8-week-old severe combined immunodeficiency (SCID) mice, and the transplants were harvested at 2, 4, 6, and 8 weeks. At 2 weeks, Dex-treated osteoblasts formed bonelike tissue, the quantity of which increased in a time-dependent manner to 8 weeks. This bonelike tissue was composed of mineralized collagen matrix newly synthesized by the transplanted osteoblasts. This mineralized matrix was separated from the osteoblasts by nonmineralized matrixlike osteoid. Furthermore, many osteocytic cells were observed in this mineralized matrix. A high expression of alkaline phosphatase (ALPase) and osteocalcin was detected in the transplanted cells surrounding the bonelike tissue. In situ hybridization for human-specific alu sequence indicated that newly formed bone was of donor origin. The transplants of nontreated cells failed to form bonelike tissue. The transplants of collagen sponge alone formed no bonelike tissue. These studies indicate that Dex-treated human osteoblasts possess the differentiated osteoblastic function and are able to form bone tissue in vivo. These new findings are of use in facilitating the application of osteoblasts to bone reconstruction.


Subject(s)
Bone and Bones/physiology , Osteoblasts/physiology , Alkaline Phosphatase/genetics , Alkaline Phosphatase/metabolism , Animals , Bone and Bones/cytology , Cell Transplantation , Cells, Cultured , Child , Collagen/metabolism , Dexamethasone/pharmacology , Gene Expression , Humans , In Situ Hybridization/methods , Male , Mice , Mice, SCID , Osteoblasts/cytology , Osteoblasts/drug effects , Osteocalcin/genetics , Osteocalcin/metabolism
13.
J Invest Dermatol ; 110(6): 889-93, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9620295

ABSTRACT

Platelet-activating factor (PAF) is a potent lipid mediator that exhibits versatile biologic activities in many diverse systems by binding to a specific cell-surface receptor (PAFR). Although the production of PAF in cultured keratinocytes and fibroblasts has been reported, physiologic roles of this mediator in skin remain unclear. In this study, we examined in situ expression of PAFR gene in rat skin and the effects of PAF on the proliferation and differentiation of cultured human keratinocytes. In rat epidermis, PAFR mRNA expression was found from the basal cells to the granular cells, and strong signals were seen in the stratum spinosum. In cultured human keratinocytes, a 3.8 kb PAFR mRNA expression was demonstrated by northern blotting, and two distinct type transcripts driven by different promoters were detected by reverse transcriptase polymerase chain reaction analysis. Addition of PAF (30-100 nM) to cultured keratinocytes during a growth phase inhibited the proliferation. This effect was receptor dependent, because the inhibition was completely blocked by a PAFR antagonist, WEB 2086 (100 nM). On the other hand, whereas PAF (30-100 nM) alone did not affect the cornified envelope formation during the process of keratinocyte differentiation, WEB 2086 (30-300 nM) accelerated it in a concentration-dependent manner. Addition of PAF (100 nM) reversed the effect of WEB 2086, suggesting that WEB 2086 induced cornification by inhibiting PAF endogeneously produced by keratinocytes in an autocrine manner. Thus, we propose that PAF is an intrinsic regulator of keratinocyte during proliferation and differentiation.


Subject(s)
Genes/genetics , Keratinocytes/cytology , Platelet Activating Factor/pharmacology , Platelet Membrane Glycoproteins/genetics , Receptors, Cell Surface , Receptors, G-Protein-Coupled , Skin/metabolism , Animals , Azepines/administration & dosage , Azepines/pharmacology , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Line , Cells, Cultured , Dose-Response Relationship, Drug , Fibrinolytic Agents/administration & dosage , Fibrinolytic Agents/pharmacology , Gene Expression/genetics , Humans , In Situ Hybridization , Keratinocytes/drug effects , Keratinocytes/metabolism , Male , Platelet Activating Factor/administration & dosage , RNA, Messenger/analysis , RNA, Messenger/genetics , Rats , Rats, Inbred Strains , Skin/chemistry , Skin/cytology , Transcription, Genetic/genetics , Triazoles/administration & dosage , Triazoles/pharmacology
14.
J Immunol Methods ; 190(1): 71-7, 1996 Mar 28.
Article in English | MEDLINE | ID: mdl-8601713

ABSTRACT

We designed a microplate-based assay method for mitogen-activated protein (MAP) kinase. Using anion-exchanger resin, MAP kinases from murine macrophages were partially purified in 96-well plates. The activities of these purified enzymes correlated well with those detected in heretofore used assays. The micro-trap phosphorylation assay has advantages over conventional methods (immunoprecipitation, Western blotting for the detection of mobility shift, or kinase detection assay in myelin basic protein (MBP)-containing gel), in terms of sensitivity, economy and rapid execution for hundreds of samples. Using micro-trap phosphorylation assay, it was demonstrated that MAP kinase activities in macrophages were persistently increased by lipopolysaccharide (LPS) stimulation, and this activation was inhibited by polymyxin B or tyrosine kinase inhibitors. This method is expected to give a wide range of application, such as determining effects of drug inhibitors or antisense oligonucleotides on MAP kinases, or measuring the various protein kinases after specificity controls were done.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/analysis , Lipopolysaccharides/pharmacology , Animals , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cell Line , Enzyme Activation , Enzyme Inhibitors/pharmacology , Macrophages/enzymology , Mice , Phosphorylation , Polymyxin B/pharmacology , Protein-Tyrosine Kinases/antagonists & inhibitors
15.
Aliment Pharmacol Ther ; 16(10): 1805-9, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12269975

ABSTRACT

BACKGROUND: Therapy for the relief of symptoms of functional dyspepsia is unpredictable. AIM: To identify which patients may benefit from antisecretory therapy. METHODS: Twenty-seven patients with functional dyspepsia were selected to receive H2-receptor antagonist (H2RA) treatment for 4 weeks. Serum pepsinogen A, pepsinogen C and gastrin were measured, and Helicobacter pylori status was determined. Symptoms were assessed at baseline and after H2RA treatment. RESULTS: Fourteen patients were identified as H2RA responders and the remaining patients were non-responders. No differences were found between responders and non-responders with regard to serum pepsinogen A, pepsinogen C, gastrin and H. pylori status. However, the pepsinogen A/C ratio was significantly higher in responders than in non-responders. Ten of the 13 functional dyspepsia patients (77%) with a high value of the pepsinogen A/C ratio (> or = 4.5) achieved symptom resolution by H2RA, compared with only one of the eight patients (13%) with a low value of the pepsinogen A/C ratio (< or = 3.0). CONCLUSIONS: The serum pepsinogen A/C ratio seems to identify those functional dyspepsia patients for whom acid control provides benefit. This ratio may be a practical tool for the management of functional dyspepsia patients.


Subject(s)
Anti-Ulcer Agents/therapeutic use , Dyspepsia/drug therapy , Histamine H2 Antagonists/therapeutic use , Pepsinogen A/blood , Piperidines/therapeutic use , Adult , Aged , Biomarkers/blood , Dyspepsia/blood , Dyspepsia/microbiology , Female , Gastrins/blood , Helicobacter pylori/isolation & purification , Humans , Male , Middle Aged , Patient Selection , Pepsinogen C/blood , Treatment Outcome
16.
J Biochem ; 101(3): 653-60, 1987 Mar.
Article in English | MEDLINE | ID: mdl-3597344

ABSTRACT

Microsomal sn-glycerol 3-phosphate acyltransferase from the guinea pig Harderian gland was studied. Its specific activity (1.0 nmol/min X mg, with palmitoyl-CoA as a substrate) was almost the same as that of the rat liver microsomal enzyme. The enzyme acted on various types of acyl-CoA, the relative reaction rates being as follows: palmitoyl-CoA, 100(%); stearoyl-CoA, 30; oleoyl-CoA, 50; linoleoyl-CoA, 40; and arachidonoyl-CoA, 20. When assayed in the presence of 1 mM 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB), the activity on palmitoyl-CoA was inhibited by only 20-30%, whereas those for other acyl-CoAs were completely abolished. The DTNB-resistant activity was inhibited by 0.1 mM dihydroxyacetonephosphate and 0.5 mM dithiothreitol, whereas the DTNB-sensitive activity was not affected. Furthermore, heat treatment at 50 degrees C for 15 min abolished most of the DTNB-sensitive activity, but not the DTNB-resistant activity. These results, taken together, suggested that the microsomal fraction of the guinea pig Harderian gland contained at least two types of sn-glycerol 3-phosphate acyltransferase, and that, in contrast to in the case of rat liver microsomes, a DTNB-resistant enzyme that utilized exclusively palmitoyl-CoA was predominant.


Subject(s)
Acyltransferases/isolation & purification , Glycerol-3-Phosphate O-Acyltransferase/isolation & purification , Harderian Gland/enzymology , Lacrimal Apparatus/enzymology , Acyl Coenzyme A/metabolism , Animals , Chromatography, High Pressure Liquid , Dithionitrobenzoic Acid/pharmacology , Drug Resistance , Guinea Pigs , Harderian Gland/cytology , Hot Temperature , Kinetics , Microsomes/enzymology
17.
Ann N Y Acad Sci ; 744: 107-25, 1994 Nov 15.
Article in English | MEDLINE | ID: mdl-7825832

ABSTRACT

Platelet-activating factor and somatostatin receptors, two G protein-coupled receptors expressed in the rat hippocampus, were analyzed for the downstream signaling pathways in Chinese hamster ovary cells stably expressing each receptor. Ligand stimulation to each CHO cell line induced (1) inhibition of forskolin-induced accumulation of cAMP, (2) arachidonate release, and (3) activation of mitogen-activated protein kinase and MAP kinase kinase. In contrast, inositol phosphate breakdown was seen only in the PAF-stimulated CHO cells. The induction of these signals accompanied no detectable Ras activation. Suppression of the signals by pertussis toxin was almost complete for the somatostatin receptor but partial for the PAF receptor, suggesting that the somatostatin receptor couples only with PTX-sensitive G protein, while the PAF receptor couples with both PTX-sensitive and -insensitive G proteins. A model of G protein-mediated signaling pathways was proposed in which the signals from Gi and those from Gq converge at MAP kinase kinase and lead to arachidonate release. The present system using CHO cells is useful for analyzing signaling pathways from G proteins to MAP kinase kinase and will thereby provide clues for understanding the mechanisms underlying the physiological and pathological events mediated by PAF, somatostatin, and other G protein-coupled receptors in the central nervous system and other tissues.


Subject(s)
Arachidonic Acid/metabolism , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , GTP-Binding Proteins/metabolism , Hippocampus/enzymology , Receptors, Cell Surface , Receptors, G-Protein-Coupled , Amino Acid Sequence , Animals , CHO Cells , Cricetinae , Enzyme Activation , Molecular Sequence Data , Platelet Membrane Glycoproteins/metabolism , Rats , Receptors, Somatostatin/metabolism , Signal Transduction
18.
FEMS Microbiol Lett ; 54(1-3): 39-43, 1990 Jan 01.
Article in English | MEDLINE | ID: mdl-2323545

ABSTRACT

Bordetella bronchiseptica dermonecrotic toxin was purified by a simplified method. The method consisted of SP Toyopearl 650M chromatography and high performance liquid chromatography on a TSK gel G3000SW column. 47.5% of the activity of the crude cell extract was recovered. The purified toxin behaved as a homogeneous protein in sodium dodecyl sulfate polyacrylamide gel electrophoresis, high performance liquid chromatography, and agar gel double diffusion tests.


Subject(s)
Bacterial Toxins/isolation & purification , Bordetella/analysis , Transglutaminases , Virulence Factors, Bordetella , Animals , Bacterial Toxins/toxicity , Chromatography , Molecular Weight , Necrosis , Polymers , Skin/drug effects , Skin/pathology
19.
FEMS Microbiol Lett ; 66(2): 143-7, 1991 Aug 01.
Article in English | MEDLINE | ID: mdl-1718817

ABSTRACT

The polysaccharide structure recognized by a monoclonal antibody specific to serotype 2 lipopolysaccharide of Actinobacillus pleuropneumoniae was investigated using an enzyme-linked immunosorbent assay inhibition test. Lipopolysaccharide obtained from serotype 2, strain SH-15, was hydrolysed with acetic acid to liberate the polysaccharide portion, and the polysaccharide mixture was fractionated by gel filtration. The longer polysaccharide, composed of O-antigenic polysaccharide and core, fully inhibited the binding of monoclonal antibodies to a whole cell antigen of strain SH-15, whereas the core oligosaccharide without O-polysaccharide did not. No inhibition was observed with the monosaccharides which were the components of serotype 2 LPS. Enzyme-linked immunosorbent assay inhibition ability of O-polysaccharide was completely lost only by O-deacetylation. These results demonstrate that the epitope of the serotype-specific monoclonal antibody resided in O-polysaccharide of LPS and that the O-acetyl group was essential for the epitope structure.


Subject(s)
Actinobacillus pleuropneumoniae/immunology , Antibodies, Monoclonal/immunology , Lipopolysaccharides/immunology , Acetylation , Antibodies, Bacterial/immunology , Carbohydrates/analysis , Chromatography, Gel , Enzyme-Linked Immunosorbent Assay , Epitopes/immunology , Lipopolysaccharides/chemistry
20.
FEMS Microbiol Lett ; 69(3): 229-34, 1992 Jan 15.
Article in English | MEDLINE | ID: mdl-1555757

ABSTRACT

The effects of Bordetella bronchiseptica dermonecrotic toxin (DNT) on the in vivo antibody response of mice were investigated. Intravenous injection of DNT at doses of 0.5 and 2.0 ng resulted in a significant suppression of the antibody response both to sheep red blood cells and to Escherichia coli lipopolysaccharide as measured by plaque-forming cell and hemagglutination assays. Spleen weights of mice given the same doses of DNT were significantly reduced, while the weights of thymuses and mesenteric lymph nodes were not. Numbers of Thy-1,2+ T lymphocytes, L3T4+ T lymphocytes, Lyt-2+ T lymphocytes and surface-immunoglobulin-positive lymphocytes decreased in spleens of the DNT-treated mice. Since the ratio of each lymphocyte population to the total number of splenic lymphocytes was not significantly different between the DNT-treated and non-treated mice, it is unlikely that DNT has a cytotoxic activity or a mitogen activity to some specific population of lymphocytes. Thus, we considered that the immunosuppression was attributable to a dysfunction of the spleen atrophied by the DNT.


Subject(s)
Antibody Formation , Bacterial Toxins/toxicity , Bordetella bronchiseptica , Immune Tolerance , Lymphocytes/immunology , Spleen/immunology , Transglutaminases , Virulence Factors, Bordetella , Animals , Female , Hemagglutination Tests , Hemolytic Plaque Technique , Lethal Dose 50 , Lymphocyte Subsets , Mice , Mice, Inbred BALB C , Organ Size
SELECTION OF CITATIONS
SEARCH DETAIL